Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-25-051570
Filing Date
2025-03-11
Accepted
2025-03-11 09:30:39
Documents
12

Document Format Files

Seq Description Document Type Size
1 S-3 d917201ds3.htm S-3 467643
2 EX-4.3 d917201dex43.htm EX-4.3 302540
3 EX-4.4 d917201dex44.htm EX-4.4 330445
4 EX-4.5 d917201dex45.htm EX-4.5 31539
5 EX-4.6 d917201dex46.htm EX-4.6 31947
6 EX-5.1 d917201dex51.htm EX-5.1 27966
7 EX-23.1 d917201dex231.htm EX-23.1 2453
8 EX-FILING FEES d917201dexfilingfees.htm EX-FILING FEES 72576
9 GRAPHIC g917201dsp1.jpg GRAPHIC 2420
10 GRAPHIC g917201dsp1a.jpg GRAPHIC 10808
11 GRAPHIC g917201g00a03.jpg GRAPHIC 45346
12 GRAPHIC g917201g01h02.jpg GRAPHIC 50124
  Complete submission text file 0001193125-25-051570.txt   1418172
Mailing Address 828 WINTER STREET WALTHAM MA 02451
Business Address 828 WINTER STREET WALTHAM MA 02451 617-833-1027
Xilio Therapeutics, Inc. (Filer) CIK: 0001840233 (see all company filings)

EIN.: 851623397 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-285703 | Film No.: 25726064
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)